Effectiveness and Tolerability of the On-demand Use of Combined Dapoxetine With Tadalafil and Combined Dapoxetine With Lidocaine 5% Spray in Treatment of Patients With Lifelong Premature Ejaculation and Non-responding to Dapoxetine Alone.

• Status: Recruiting
• Trial end date: 2021-01-30
• Target enrollment: 0
• Participant gender: Male

Summary

Therefore, this study will aim to assess the effectiveness and tolerability of the on-demand use of combined dapoxetine with tadalafil and combined dapoxetine with lidocaine 5% spray in treatment of patients with lifelong premature ejaculation and non-responding to dapoxetine alone.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sohag University
• Treatments: Lidocaine; Tadalafil

Criteria

Inclusion Criteria:

• lifelong premature ejaculation and non-responding to dapoxetine alone.

Exclusion Criteria:

• diabetes mellitus,

• chronic prostatitis,

• Advanced renal or hepatic diseases

• neurological diseases

• C.N.S. medications